Access Industries Amends Elicio Therapeutics Stake

TL;DR

Access Industries updated their Elicio Therapeutics filing, watch for changes.

AI Summary

Access Industries Holdings LLC, along with related entities and individuals including Len Blavatnik, Alejandro Moreno, and Langhorne S. Perrow, has filed an amendment (No. 4) to their Schedule 13D concerning Elicio Therapeutics, Inc. The filing, dated April 10, 2024, indicates a change in beneficial ownership. Access Industries Holdings LLC is based in New York, NY, and Elicio Therapeutics, Inc. is headquartered in Boston, MA.

Why It Matters

This filing signals a potential shift in control or significant influence over Elicio Therapeutics by Access Industries, which could impact the company's strategic direction and stock performance.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can precede significant corporate actions or shifts in strategy, introducing uncertainty.

Key Players & Entities

• Access Industries Holdings LLC (company) — Filing entity
• Elicio Therapeutics, Inc. (company) — Subject company
• Len Blavatnik (person) — Group member
• Alejandro Moreno (person) — Contact person
• Langhorne S. Perrow (person) — Contact person
• Clal Biotechnology Industries Ltd. (company) — Filing entity

FAQ

Key Financial Figures

• $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
• $60.77 — of Common Stock at an exercise price of $60.77 are owned directly by CBI and each of A
• $6.5638 — on Stock at a weighted average price of $6.5638 in open market transactions. 1 On Mar
• $6.7500 — 06 shares of Common Stock at a price of $6.7500 in open market transactions. 1 The s
• $6.81 — d in multiple transactions ranging from $6.81 to $6.50, inclusive. The Reporting Pers
• $6 — iple transactions ranging from $6.81 to $6.50, inclusive. The Reporting Persons un
• $6.6299 — on Stock at a weighted average price of $6.6299 in open market transactions. 2 On Mar
• $6.9144 — on Stock at a weighted average price of $6.9144 in open market transactions. 3 On Mar
• $7.0237 — on Stock at a weighted average price of $7.0237 in open market transactions. 4 On Mar
• $7.3000 — on Stock at a weighted average price of $7.3000 in open market transactions. 5 On Mar
• $7.8000 — 59 shares of Common Stock at a price of $7.8000 in open market transactions. On April
• $7.2500 — 10 shares of Common Stock at a price of $7.2500 in open market transactions. On April
• $7.5398 — on Stock at a weighted average price of $7.5398 in open market transactions. 6 On Apr
• $7.4948 — on Stock at a weighted average price of $7.4948 in open market transactions. 7 On Apr
• $7.5000 — 00 shares of Common Stock at a price of $7.5000 in open market transactions. On April

Filing Documents

• d814407dsc13da.htm (SC 13D/A) — 115KB
• d814407dex998.htm (EX-99.8) — 11KB
• 0001193125-24-091853.txt ( ) — 127KB

From the Filing

SC 13D/A 1 d814407dsc13da.htm SC 13D/A SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Elicio Therapeutics, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 28657F103 (CUSIP Number) Alejandro Moreno Langhorne S. Perrow c/o Access Industries, Inc. 40 West 57th Street, 28th Floor New York, New York 10019 (212) 247-6400 with copies to: Nicholas P. Pellicani Debevoise & Plimpton LLP 65 Gresham Street EC2V 7NQ London + 44 20 7786 9000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 8, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. CUSIP No. 28657F103 1 NAME OF REPORTING PERSON. Access Industries Holdings LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) SC NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 481,727 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 481,727 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 481,727 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 4.68% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) All percentages of ownership of the Common Stock by Reporting Persons presented in this Statement are based on an aggregate of 10,235,469 shares of Common Stock issued and outstanding as of March 26, 2024, as set forth in the Issuers annual report on Form 10-K, filed with the Securities and Exchange Commission (the SEC) on March 29, 2024. CUSIP No. 28657F103 1 NAME OF REPORTING PERSON. Access Industries, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) SC NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 481,727 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 481,727 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 481,727 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 4.68% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) All percentages of ownership of the Common Stock by Reporting Persons presented in this Statement are based on an aggregate of 10,235,469 shares of Common Stock issued and outstanding as of March 26, 2024, as set forth in the Issuers annual report on Form 10-K, filed with the SEC on March 29, 2024. CUSIP No. 28657F103 1 NAME OF REPORTING PERSON. Access Industries Management, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) SC NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 481,727 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 481,727 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 481,727 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 4.68% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) All percentages of ownership of the Common Stock by Reporting Persons presented in this Statement are based on an aggregate of 10,235,469 shares of Common Stock issued and outstanding as of March 26, 2024, as set forth in the Issuers annual report on Form 10-K, filed with the SEC on March 29, 2024. CUSIP No. 28657F103 1 NAME OF REPORTING PERSON. Clal Industries Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) SC

View Full Filing

View this SC 13D/A filing on SEC EDGAR